1. Sarig G, Younis JS, Hoffman R, et al. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002;77(2):342-347.
2. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost. 2001;86(1):104-111.
3. Carp H, Salomon O, Seidman D, et al. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002;17(6):1633-1637.
4. Prandoni P, Tormene D, Simioni P, Girolami A. Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia. Clin Lab. 2001;47(3-4):155-159.
5. Di Micco P, D'Uva M, Strina I, et al. Recurrent pregnancy loss and thrombophilia. J Clin Med Res. 2010 Feb; 2(1):18-22.
6. Di Micco P, D'Uva M. Recurrent pregnancy loss and thrombophilia. The Open Atherosclerosis & Thrombosis Journal. 2009;2:33-35.
7. Kwak-Kim J, Park JC, Ahn HK, et al. Immunological modes of pregnancy loss. Am J Reprod Immunol. 2010;63(6):611-623.
8. Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriages. Hum Reprod Update. 2003;9(2):163-174.
9. Dosiou C, Giudice KC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocrin Rev. 2005;26(1):44-62.
10. Han G, Chen Y, Xu J, et al. The regulation of ovary and conceptus on the uterine natural killer cells during early pregnancy. Reprod Biol Endocrinol. 2017;15:73.
11. Zhu L, Aly M, Wang H, et al. Increased natural killer cell subestes with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplants recipients late post transplant. Clin Exp Immunol. 2018;193(2):241-254.
12. Chen X, Mariee N, Jiang L, et al. Measurement of uterine natural killer cell percentage in periimplantation endometrium from fertile women and women with recurrent reproductive failure: establishment of a reference range. Am JObstetric Gynecol .2017;217(6):680-686.